Breaking News
Sort by:
Top Post
Novalis Biotech Invests in Ultra Sensitive Genomics Technology by Rarity Bioscience
Rarity Bioscience announces a new strategic investment from Belgium-based Novalis Biotech. The investment is facilitated […]
Dantari Debuts with $47 Million Series A to Advance Best-in-Class Targeted Medicines for Solid Tumors
Dantari, a clinical-stage biotechnology company developing best-in-class targeted therapeutics for the treatment of cancers and […]
ExPLoRNA Therapeutics Receives Funding to Advance its Novel mRNA Technology
ExPLoRNA Therapeutics, a Polish biotech company revolutionizing mRNA vaccines and therapeutics with unprecedented translational efficiency, […]
Enthea Announces Nationwide Rollout to Offer Psychedelic Therapy as a Workplace Benefit
Enthea, the first provider of insurance plans for psychedelic healthcare, announces its successful $2M seed […]
BRIM Biotechnology Raises $20 Million in Series E Funding Round
BRIM Biotechnology, a clinical-stage biotechnology company advancing novel regenerative therapies to help combat and cure […]
New Funding of $2 Million for Research Bringing Us One Step Closer to a Cure for Follicular Lymphoma
The Follicular Lymphoma Foundation (FLF) today announced it has awarded four research grants of up to […]
Escient Pharmaceuticals Announces $120 Million Series C Financing
Escient Pharmaceuticals, a clinical-stage company advancing novel small molecule therapeutics for the potential treatment of […]
HHS Awards ICF Over $45 Million in Digital Modernization Contracts
The U.S. Department of Health and Human Services‘ (HHS) Centers for Medicare & Medicaid Services […]
Nyra Medical Announces $20 Million Series A Funding for its Transcatheter Heart Valve Repair Technology
Nyra Medical, a medical device company that is developing a novel transcatheter mitral valve repair […]
Hemispherian Raises First Tranche of Series A to Fund the Development of its Novel Cancer Therapeutics
Hemispherian AS, a Norwegian preclinical pharmaceutical company focused on small molecule cancer therapeutics targeting the […]
RedBrick AI Raises US$4.6M in Funding to Accelerate the Development of Healthcare AI
Health-tech AI platform RedBrick AI is today announcing a US$4.6M seed funding round to accelerate the […]
- Eloxx Pharmaceuticals Announces Final Data Assessment from Phase 2 Combination Clinical Trial of ELX-02 in Class 1 Cystic Fibrosis Patients Read more
- Verge Genomics Announces Positive Safety and Tolerability Data from the Phase 1 Clinical Trial of VRG50635, a Potential Best-in-Class Therapeutic for All Forms of ALS Read more
- DEM BioPharma Appoints Wendy Young, Ph.D., to Scientific Advisory Board Read more
- Confo Therapeutics Enters into Research Collaboration for GPCR-Targeting Antibody Discovery with AbCellera Read more
- Vyriad Announces Expansion of T-Cell Lymphoma Trial at Mayo Clinic Read more